US EditionLeadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced a key leadership transition as founder and Chief Medical Officer Dr. Rebecca Taub steps into the role of Senior Scientific and Medical Advisor while continuing her position on the company’s Board of Directors. Succeeding her, Dr. David Soergel will assume the role of Executive Vice President and Chief Medical Officer, effective April 21, 2025. Dr. Taub, a pioneer in b…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
